These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Respiratory Syncytial Virus-Induced Oxidative Stress Leads to an Increase in Labile Zinc Pools in Lung Epithelial Cells. Khan NA; Singla M; Samal S; Lodha R; Medigeshi GR mSphere; 2020 May; 5(3):. PubMed ID: 32461278 [TBL] [Abstract][Full Text] [Related]
6. Marked induction of matrix metalloproteinase-10 by respiratory syncytial virus infection in human nasal epithelial cells. Hirakawa S; Kojima T; Obata K; Okabayashi T; Yokota S; Nomura K; Obonai T; Fuchimoto J; Himi T; Tsutsumi H; Sawada N J Med Virol; 2013 Dec; 85(12):2141-50. PubMed ID: 24009192 [TBL] [Abstract][Full Text] [Related]
7. Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells. Guo X; Liu T; Shi H; Wang J; Ji P; Wang H; Hou Y; Tan RX; Li E J Virol; 2015 Aug; 89(15):7636-45. PubMed ID: 25972545 [TBL] [Abstract][Full Text] [Related]
8. Central Role of the NF-κB Pathway in the Tian B; Yang J; Zhao Y; Ivanciuc T; Sun H; Wakamiya M; Garofalo RP; Brasier AR J Virol; 2018 Jun; 92(11):. PubMed ID: 29593031 [TBL] [Abstract][Full Text] [Related]
9. CX3CR1 as a respiratory syncytial virus receptor in pediatric human lung. Anderson CS; Chu CY; Wang Q; Mereness JA; Ren Y; Donlon K; Bhattacharya S; Misra RS; Walsh EE; Pryhuber GS; Mariani TJ Pediatr Res; 2020 Apr; 87(5):862-867. PubMed ID: 31726465 [TBL] [Abstract][Full Text] [Related]
10. N-acetyl-L-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV). Mata M; Morcillo E; Gimeno C; Cortijo J Biochem Pharmacol; 2011 Sep; 82(5):548-55. PubMed ID: 21635874 [TBL] [Abstract][Full Text] [Related]
11. Respiratory Syncytial Virus induces the classical ROS-dependent NETosis through PAD-4 and necroptosis pathways activation. Muraro SP; De Souza GF; Gallo SW; Da Silva BK; De Oliveira SD; Vinolo MAR; Saraiva EM; Porto BN Sci Rep; 2018 Sep; 8(1):14166. PubMed ID: 30242250 [TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus lung infection in infants: immunoregulatory role of infected alveolar macrophages. Midulla F; Villani A; Panuska JR; Dab I; Kolls JK; Merolla R; Ronchetti R J Infect Dis; 1993 Dec; 168(6):1515-9. PubMed ID: 8245538 [TBL] [Abstract][Full Text] [Related]
13. ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation. González-Sanz R; Mata M; Bermejo-Martín J; Álvarez A; Cortijo J; Melero JA; Martínez I J Virol; 2016 Jan; 90(7):3428-38. PubMed ID: 26763998 [TBL] [Abstract][Full Text] [Related]
14. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor. Coates M; Brookes D; Kim YI; Allen H; Fordyce EAF; Meals EA; Colley T; Ciana CL; Parra GF; Sherbukhin V; Stockwell JA; Thomas JC; Hunt SF; Anderson-Dring L; Onions ST; Cass L; Murray PJ; Ito K; Strong P; DeVincenzo JP; Rapeport G Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652242 [TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus disrupts the airway epithelial barrier by decreasing cortactin and destabilizing F-actin. Gao N; Raduka A; Rezaee F J Cell Sci; 2022 Aug; 135(16):. PubMed ID: 35848790 [TBL] [Abstract][Full Text] [Related]
16. Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus. Wang KC; Chang JS; Lin LT; Chiang LC; Lin CC Am J Chin Med; 2012; 40(5):1033-45. PubMed ID: 22928833 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells. Arnold R; Neumann M; König W Immunology; 2007 May; 121(1):71-81. PubMed ID: 17425601 [TBL] [Abstract][Full Text] [Related]
18. Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures. Broadbent L; Parke HG; Ferguson LJ; Millar A; Shields MD; Detalle L; Power UF Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767728 [TBL] [Abstract][Full Text] [Related]
19. Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specific. Levitz R; Wattier R; Phillips P; Solomon A; Lawler J; Lazar I; Weibel C; Kahn JS Virol J; 2012 Sep; 9():190. PubMed ID: 22962966 [TBL] [Abstract][Full Text] [Related]